Collaborative Heart Attack Management Program (CHAMP): use of prehospital thrombolytics to improve timeliness of

Andrew Guy1,2, Nicki Gabers3, Chase Crisfield3

  • 1Department of Emergency Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada andrew.guy@alumni.ubc.ca.

BMJ Open Quality
|December 7, 2021
PubMed

Insights

Prehospital thrombolysis (PHT) significantly reduced treatment times for ST-elevation myocardial infarction (STEMI) in Canada. This quality improvement initiative cut median first medical contact to needle time by 70%, improving patient outcomes and saving costs.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Health Services Research

Background:

  • Coronary artery disease is a leading cause of death in Canada.
  • ST-elevation myocardial infarction (STEMI) treatment delays increase morbidity and mortality.
  • Prehospital thrombolysis (PHT) is a strategy to reduce treatment times in remote areas.

Purpose of the Study:

  • To implement and evaluate a quality improvement initiative for PHT in STEMI patients.
  • To decrease the time from first medical contact (FMC) to thrombolysis administration.
  • To assess the feasibility, effectiveness, and cost-impact of PHT.

Main Methods:

  • A quality improvement framework was used, involving collaboration with multiple stakeholders.
  • Advanced care paramedics were trained to administer thrombolysis with remote cardiologist support.
  • The study aimed for a median FMC to needle time of <30 minutes in 80% of patients.

Main Results:

  • Median FMC to needle time was reduced by 70%, from 84 minutes at baseline to 25 minutes with PHT.
  • The percentage of patients treated within the guideline-recommended <30 minutes increased from 0% to 61%.
  • The intervention demonstrated a positive return on investment, saving $2.80 in acute care costs for every $1.00 spent.

Conclusions:

  • PHT significantly reduces FMC to needle time for STEMI patients, despite not reaching the 80% target for guideline-recommended times.
  • The initiative proved cost-effective, offering substantial savings in acute care costs.
  • Ongoing implementation and expansion of PHT to other communities are planned.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
47
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
111
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
41
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
63
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
61
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
106